Monday, January 04, 2021 10:14:28 AM
61% YOY gains.
CASH FLOW POSITIVE 2 quarters in a row.
Forward PE 5.6
6 straight quarters of double and triple digit gains YOY
No obligation to SunGen for GodZilla the $2.0 Billion CNS stinulant. CNS stimulant fully owned by Elite. ALL in on this one. $2 Billion IQVIA market
Elite doing All R&D in-house currently
Loxapine API imminent due any day from India
Loxapine on Drug Shortage List
Loxapine launch 1st quarter 2021
Loxapine $5 million IQVIA market with 4 competitors
Elite has a sales and marketing partner in place for Loxapine
Elite has competitive advantage on high entry barrier ER formulas
$2.484 million profit this quarter
Isradipine has upside potential
Elite streamlining using SAP technology
No obligation to SunGen for GodZilla the $1.5 Billion CNS stinulant.
Debt to market cap : 7%
“Elite is attractive for Merger or BuyOut”
Adderall IR and ER have strong UPSIDE POTENTIAL $2 billion combined market
New Equipment for production line - NEW 30 cubic foot V-blender
NEW higher speed tablet press. Facility upgrades.
One shift can do 300 million capsules a month.
Upgraded the Packaging Line - capacity increased by 25%
Back to school Adderall
Lannett Glenmark and Tagi continue to penetrate the markets
Walgreens Largest Customer 15% of market
$75 million tax credit, no taxes on first $75 million profit.
49% profitability
FDA reviewing $94 million SunGen Antibiotic ANDA waiting on response from FDA
Elite will reacquire full rights to Adderall IR and ER which Nasrat paid millions via Micah to protect these interests until Elite can take full control / ownership of them
Partnerships, merger, contract development, licensing opportunities, contract manufacturing, new ANDAs etc
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM